🏢 官网IRIONSCodex · 实盘不做把握 9/10
北京时间·🕒 发布 19:05:00时区推断·⟳ 抓取 19:07:09回填·⚡ 决策 07-15 19:08:15·103.9 天前
Ionis宣布将于7月29日召开二季度业绩电话会
这只是公司例行披露业绩电话会时间安排，没有发布业绩数据、指引变化、临床进展或商业化增量。
📄 原文IONS↗ 原文
Ionis to hold second quarter 2026 financial results webcast
Skip to main navigation Release Details Ionis to hold second quarter 2026 financial results webcast July 15, 2026 PDF V…
不做 Ionis Pharmaceuticals（IONS.US）
例行业绩电话会预告，无业绩数据、指引上修、管线进展或商业化增量，无法形成正期望交易，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-15 · 扩散 low · price-in 风险 low ↗
关键理由
- 这只是公司例行披露业绩电话会时间安排，没有发布业绩数据、指引变化、临床进展或商业化增量。
主要风险
- 若7月29日正式业绩会出现超预期数据或关键管线进展，应按新事件重新评估。
原文全文
展开原文 · 1,633 字
Skip to main navigation
Release Details
Ionis to hold second quarter 2026 financial results webcast
July 15, 2026
PDF Version
Webcast scheduled for Wednesday, July 29 at 8:30 a.m. Eastern Time
CARLSBAD, Calif. --(BUSINESS WIRE)--Jul. 15, 2026-- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, July 29 at 8:30 a.m. Eastern Time to discuss its second quarter 2026 financial results and highlight progress on key programs.
The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events . A replay will be available for a limited time at the same address.
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has marketed medicines and a leading pipeline in neurology, cardiometabolic disease and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram .
View source version on businesswire.com: https://www.businesswire.com/news/home/20260715218889/en/
Ionis Investor Contact:
D. Wade Walke, Ph.D. – IR@ionis.com – 760-603-2331
Ionis Media Contact:
Hayley Soffer – media@ionis.com – 760-603-4679
Source: Ionis Pharmaceuticals, Inc.
Release Details
Ionis to hold second quarter 2026 financial results webcast
July 15, 2026
PDF Version
Webcast scheduled for Wednesday, July 29 at 8:30 a.m. Eastern Time
CARLSBAD, Calif. --(BUSINESS WIRE)--Jul. 15, 2026-- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, July 29 at 8:30 a.m. Eastern Time to discuss its second quarter 2026 financial results and highlight progress on key programs.
The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events . A replay will be available for a limited time at the same address.
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has marketed medicines and a leading pipeline in neurology, cardiometabolic disease and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram .
View source version on businesswire.com: https://www.businesswire.com/news/home/20260715218889/en/
Ionis Investor Contact:
D. Wade Walke, Ph.D. – IR@ionis.com – 760-603-2331
Ionis Media Contact:
Hayley Soffer – media@ionis.com – 760-603-4679
Source: Ionis Pharmaceuticals, Inc.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。